This symposium, which took place on 1st December 2022 as part of the European Academy of Allergy and Clinical Immunology (EAACI) FAAM-EUROBAT Digital Conference presented new evidence on the role of human milk oligosaccharides (2 fucosyllactose and lacto-N-neotetraose) in supporting development of the infant microbiota, modulating the immune system, and ultimately improving the clinical management of cow’s milk protein allergy.
Allergy & Immunology